Cargando…
Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma
Glioblastoma (GBM) is an aggressive primary human brain tumour that has resisted effective therapy for decades. Although glucose and glutamine are the major fuels that drive GBM growth and invasion, few studies have targeted these fuels for therapeutic management. The glutamine antagonist, 6-diazo-5...
Autores principales: | Mukherjee, Purna, Augur, Zachary M., Li, Mingyi, Hill, Collin, Greenwood, Bennett, Domin, Marek A., Kondakci, Gramoz, Narain, Niven R., Kiebish, Michael A., Bronson, Roderick T., Arismendi-Morillo, Gabriel, Chinopoulos, Christos, Seyfried, Thomas N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541653/ https://www.ncbi.nlm.nih.gov/pubmed/31149644 http://dx.doi.org/10.1038/s42003-019-0455-x |
Ejemplares similares
-
On the Origin of ATP Synthesis in Cancer
por: Seyfried, Thomas N., et al.
Publicado: (2020) -
The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer
por: Zhou, Weihua, et al.
Publicado: (2007) -
Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer
por: Seyfried, Thomas N., et al.
Publicado: (2020) -
Nontoxic Targeting of Energy Metabolism in Preclinical VM-M3 Experimental Glioblastoma
por: Augur, Zachary M., et al.
Publicado: (2018) -
Metabolic management of microenvironment acidity in glioblastoma
por: Seyfried, Thomas N., et al.
Publicado: (2022)